Studies on the molecular mechanism of bioactivation of the selective nigrostriatal toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.

No abstract is available for this paper.

• Publication year

  1985

• Venue

  Drug Metabolism And Disposition

• Publication date

  1985-05-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  PMID 2861994
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Chronic parkinsonism secondary to intranasal administration of a product of meperidine-analogue synthesis.

  1984cited by this paper
• Intraneuronal generation of a pyridinium metabolite may cause drug-induced parkinsonism

  1984cited by this paper
• Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase inhibitors

  1984cited by this paper
• Neurochemical and behavioral effects of systemic and intranigral administration of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the rat.

  1984cited by this paper
• Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine in mice.

  1984cited by this paper
• 1-Methyl-4-phenylpyridinium ion (MPP+): identification of a metabolite of MPTP, a toxin selective to the substantia nigra.

  1984cited by this paper
• N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) affects locomotor activity without producing a nigrostriatal lesion in the rat.

  1984cited by this paper
• Pargyline prevents MPTP-induced parkinsonism in primates.

  1984cited by this paper
• Selective nigral toxicity after systemic administration of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyrine (MPTP) in the squirrel monkey.

  1984cited by this paper
• Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidase.

  1984cited by this paper
• 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine destroys dopamine neurons in explants of rat embryo mesencephalon.

  1984cited by this paper
• A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.

  1983cited by this paper
• Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis.

  1983cited by this paper
• Metabolic formation of iminium species: metabolism of phencyclidine.

  1982cited by this paper
• Metabolism of phencyclidine. The role of iminium ion formation in covalent binding to rabbit microsomal protein.

  1982cited by this paper
• The presence of the type A form of monoamine oxidase within nigrostriatal dopamine-containing neurons.

  1980cited by this paper
• Trapping of metabolically generated electrophilic species with cyanide ion: metabolism of 1-benzylpyrrolidine.

  1980cited by this paper
• Chronic Parkinsonism secondary to intravenous injection of meperidine analogues.

  1979cited by this paper
• Oxidative pathways for catecholamines in the genesis of neuromelanin and cytotoxic quinones.

  1978cited by this paper
• Subcellular localization of types A and B monoamine oxidase in rat brain.

  1977cited by this paper
• EVIDENCE FOR A SINGLE CATALYTIC BINDING SITE ON HUMAN BRAIN TYPE B MONOAMINE OXIDASE

  1976cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper

• Activation of ROS-PERK-TFEB by Filbertone Ameliorates Neurodegenerative Diseases via Enhancing the Autophagy-Lysosomal Pathway.

  2023cites this paper
• Utilizing mechanistic organic chemistry training to study drug metabolism in preclinical drug discovery/development

  2023cites this paper
• GUCY2C signaling limits dopaminergic neuron vulnerability to toxic insults

  2023cites this paper
• Reviewing the mitochondrial dysfunction paradigm in rodent models as platforms for neuropsychiatric disease research.

  2022cites this paper
• Mitolysosome exocytosis, a mitophagy-independent mitochondrial quality control in flunarizine-induced parkinsonism-like symptoms

  2022cites this paper
• Neurotoxin-Induced Rodent Models of Parkinson’s Disease: Benefits and Drawbacks

  2021cites this paper
• Tyrosine hydroxylase as a sentinel for central and peripheral tissue responses in Parkinson's progression: Evidence from clinical studies and neurotoxin models.

  2018cites this paper
• Monoamine Oxidase (MAO-N) Whole Cell Biocatalyzed Aromatization of 1,2,5,6-Tetrahydropyridines into Pyridines

  2018cites this paper
• Characterization of Mice with Altered Dopamine Transporter and Vesicular Monoamine Transporter 2 Levels

  2017cites this paper
• Les neurones à calrétinine du striatum : comparaisons inter-espèces et études anatomopathologiques

  2017cites this paper
• Drug Metabolism and Oxidative Stress: Cellular Mechanism and New Therapeutic Insights

  2016cites this paper
• Special Section on Emerging Novel Enzyme Pathways in Drug Metabolism — Commentary Cytochrome P 450 and Non – Cytochrome P 450 Oxidative Metabolism : Contributions to the Pharmacokinetics , Safety , and Efficacy of Xenobiotics

  2016cites this paper
• Neuroprotective Effect of Coptis chinensis in MPP[Formula: see text] and MPTP-Induced Parkinson's Disease Models.

  2016cites this paper
• Cytochrome P450 and Non–Cytochrome P450 Oxidative Metabolism: Contributions to the Pharmacokinetics, Safety, and Efficacy of Xenobiotics

  2016cites this paper
• Influence of different neuroprotective drugs on dopamine neurotoxicity induced by 3,4-methylenedioxymethamphetamine and MPTP in mice

  2016influential citation
• Metformin, besides exhibiting strong in vivo anti-inflammatory properties, increases mptp-induced damage to the nigrostriatal dopaminergic system.

  2016cites this paper
• SIRT3 Attenuates MPTP-Induced Nigrostriatal Degeneration Via Enhancing Mitochondrial Antioxidant Capacity

  2015cites this paper
• Increased expression of the dopamine transporter leads to loss of dopamine neurons, oxidative stress and l-DOPA reversible motor deficits.

  2015cites this paper
• Activation and Deactivation of 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine by Cytochrome P450 Enzymes and Flavin-Containing Monooxygenases in Common Marmosets (Callithrix jacchus)

  2015cites this paper
• Preferential Extracellular Generation of the Active Parkinsonian Toxin MPP+ by Transporter-Independent Export of the Intermediate MPDP+

  2015cites this paper
• Fundamentals of Organic Chemistry as Applicable to the Biotransformation of Foreign Compounds

  2014cites this paper
• Gastrodin Protects Apoptotic Dopaminergic Neurons in a Toxin-Induced Parkinson's Disease Model

  2013influential citation
• Dottorato di Ricerca in Tossicologia - Indirizzo Farmacologia e Farmacoterapia delle Tossicodipendenze Ciclo XXVI

  2013cites this paper
• Role of the prolyl isomerase Pin1 in the pathogenesis of Parkinson's disease and neuroprotection by novel targeted compounds in pre-clinical animal models of the disease

  2012cites this paper
• Neurotoxin-based models of Parkinson's disease.

  2012cites this paper
• Metabolism of 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine by Mitochondrion-targeted Cytochrome P450 2D6

  2012cites this paper
• Laser Raman detection of platelet as a non-invasive approach for early and differential diagnosis of Alzheimer's disease

  2011cites this paper
• Therapeutic Effects of Hydrogen in Animal Models of Parkinson's Disease

  2011cites this paper
• Nrf2-mediated neuroprotection in the MPTP mouse model of Parkinson's disease: Critical role for the astrocyte

  2009cites this paper
• Studies on the interactions of tobacco leaf and tobacco smoke constituents and monoamine oxidase

  2009cites this paper
• Non-toxic concentrations of α-synuclein exacerbate Parkinson's disease-like cell death by inducing mitochondrial dysfunction

  2008cites this paper
• The MPTP Mouse Model of Parkinson's Disease: the True, the False, and the Unknown

  2008cites this paper
• The synthesis and evaluation of N-methyl-2-phenylmaleimide analogues as inhibitors of MAO-B

  2008cites this paper
• Chemical genomic profiling for identifying intracellular targets of toxicants producing Parkinson's disease.

  2007cites this paper
• In Vitro Metabolism of the Analgesic Bicifadine in the Mouse, Rat, Monkey, and Human

  2007influential citation
• Behavioral motor recovery in the 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine‐lesioned squirrel monkey (Saimiri sciureus): Changes in striatal dopamine and expression of tyrosine hydroxylase and dopamine transporter proteins

  2006cites this paper
• The preparation and evaluation of xanthinyl analogues as inhibitors of monoamine oxidase B

  2006cites this paper
• Dopamine-derived dopaminochrome promotes H(2)O(2) release at mitochondrial complex I: stimulation by rotenone, control by Ca(2+), and relevance to Parkinson disease.

  2005cites this paper
• A comprehensive listing of bioactivation pathways of organic functional groups.

  2005cites this paper
• The cytotoxic activity of lactoperoxidase: enhancement and inhibition by neuroactive compounds.

  2004cites this paper
• Inhibition of human MAO-A and MAO-B by a compound isolated from flue-cured tobacco leaves and its neuroprotective properties in the MPTP mouse model of neurodegeneration

  2004cites this paper
• Nikkomycin biosynthesis: formation of a 4-electron oxidation product during turnover of NikD with its physiological substrate.

  2004cites this paper
• Tobacco leaf, smoke and smoking, MAO inhibitors, Parkinson's disease and neuroprotection; are there links?

  2004cites this paper
• MPTP as a Mitochondrial Neurotoxic Model of Parkinson's Disease

  2004cites this paper
• Inactivation of acetylcholinesterase by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine hydrochloride

  2003cites this paper
• Monoamine oxidase B inhibition and neuroprotection

  2003cites this paper
• Neuroplasticity in the MPTP‐Lesioned Mouse and Nonhuman Primate

  2003cites this paper
• Inhibition of monoamine oxidase B by selective adenosine A2A receptor antagonists.

  2003cites this paper
• Synthesis and biological evaluation of MAO-A selective 1,4-disubstituted-1,2,3,6-tetrahydropyridinyl substrates.

  2002cites this paper
• tert-Butoxyl as a model for radicals in biological systems: caveat emptor.

  2001cites this paper
• In vitro characterization of the metabolism of haloperidol using recombinant cytochrome p450 enzymes and human liver microsomes.

  2001cites this paper
• Neuroprotection in the MPTP Parkinsonian C57BL/6 mouse model by a compound isolated from tobacco.

  2001cites this paper
• Interactions of nitrogen-containing xenobiotics with monoamine oxidase (MAO) isozymes A and B: SAR studies on MAO substrates and inhibitors.

  2001cites this paper
• Isolation and characterization of a monoamine oxidase inhibitor from tobacco leaves.

  2000cites this paper
• Oxidative Metabolic Bioactivation of Xenobiotics

  1999cites this paper
• Metabolic Studies on 1-Cyclopropyl-4-phenyl-1,2,3,6-tetrahydropyridinyl Derivatives by HPLC and LC-ESI/MS

  1999cites this paper
• Species-dependent differences in monoamine oxidase A and B-catalyzed oxidation of various C4 substituted 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridinyl derivatives.

  1999cites this paper
• Local striatal infusion of MPP+ does not result in increased hydroxylation after systemic administration of 4-hydroxybenzoate.

  1999cites this paper
• 1‐Methyl‐4‐phenyl‐2,3‐dihydropyridinium is transformed by ubiquinone to the selective nigrostriatal toxin 1‐methyl‐4‐phenylpyridinium

  1999cites this paper
• MPTP-Induced Modulation of Neurotransmitters in SH-SY5Y Human Neuroblastoma Cells

  1998cites this paper
• The Nigrostriatal Toxicity of Beta-Carbolines

  1998cites this paper
• MPTP affects cholinergic parameters in SH-SY5Y human neuroblastoma cells

  1997cites this paper
• MPTP: A Dopaminergic Neurotoxin

  1997cites this paper
• N-Methylation of Beta-Carbolines as a Potential Bioactivation Route in Parkinson's Disease

  1997cites this paper
• The neuronal nitric oxide synthase inhibitor 7-nitroindazole also inhibits the monoamine oxidase-B-catalyzed oxidation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.

  1997cites this paper
• Metabolic bioactivation reactions potentially related to drug toxicities.

  1997cites this paper
• Potential metabolic bioactivation pathways involving cyclic tertiary amines and azaarenes.

  1997cites this paper
• Highly Selective Neurotoxins

  1997influential citation
• Synthesis and monoamine oxidase B catalyzed oxidation of C-4 heteroaromatic substituted 1,2,3,6-tetrahydropyridine derivatives.

  1996cites this paper
• Inhibition of acetylcholinesterase by the neurotoxicant, 1-methyl-4-phenyl-2,3-dihydropyridinium ion.

  1996cites this paper
• Neurotoxicity of 1,2,3,4-tetrahydro-2-methyl-4,6,7-isoquinolinetriol (TMIQ) and effects on catecholamine homeostasis in SH-SY5Y cells.

  1996cites this paper
• Mass spectrometry in Parkinson's disease.

  1995cites this paper
• Selective inhibitors of monoamine oxidase (MAO‐A and MAO‐B) as probes of its catalytic site and mechanism

  1995cites this paper
• N-oxygenation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine by the rat liver flavin-containing monooxygenase expressed in yeast cells.

  1995cites this paper
• Novel 4-(aryloxy)tetrahydropyridine analogs of MPTP as monoamine oxidase A and B substrates.

  1994cites this paper
• 1-Methyl-4-phenylpyridinium-like neurotoxicity of a pyridinium metabolite derived from haloperidol: cell culture and neurotransmitter uptake studies.

  1994cites this paper
• Generation of reactive oxygen species during the monoamine oxidase-catalyzed oxidation of the neurotoxicant, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.

  1993cites this paper
• Acetylcholinesterase inhibition by 1-methyl-4-phenylpyridinium ion, a bioactivated metabolite of MPTP

  1993cites this paper
• Development of fluorinated 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine analogs with potent nigrostriatal toxicity for potential use in positron emission tomography studies.

  1993cites this paper
• Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydroxypyridine (MPTP) on ganglionic transmission.

  1992cites this paper
• EPR kinetic studies of superoxide radicals generated during the autoxidation of 1-methyl-4-phenyl-2,3-dihydropyridinium, a bioactivated intermediate of parkinsonian-inducing neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.

  1992cites this paper
• Evidence for drug metabolism as a source of reactive species in the brain.

  1992cites this paper
• Free Radicals and Aging

  1992cites this paper
• Enhanced hydroxyl radical generation by 2′‐methyl analog of MPTP: Suppression by clorgyline and deprenyl

  1992cites this paper
• Superoxide radical production during the autoxidation of 1-methyl-4-phenyl-2,3-dihydropyridinium perchlorate.

  1992cites this paper
• Characteristics of Dopaminergic Neurotoxicity Produced by MPTP and Methamphetamine a

  1992cites this paper
• Synthesis of novel MPTP analogs as potential monoamine oxidase B (MAO-B) inhibitors.

  1992cites this paper
• Electronic and Conformational Effects on the Lipophilicity of Isomers and Analogs of the Neurotoxin 1‐Methyl‐4‐phenylpyridinium (MPP+)

  1991cites this paper
• Biochemical mechanisms of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity. Could oxidative stress be involved in the brain?

  1991cites this paper
• The In Vitro Metabolic Fate of (S)-Nicotine

  1991cites this paper
• Biochemical mechanisms of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity. Could oxidative stress be involved in the brain?

  1991cites this paper
• Dopaminergic Neurotoxicity In Vivo and Inhibition of Mitochondrial Respiration In Vitro by Possible Endogenous Pyridinium‐Like Substances

  1991cites this paper
• Pyridine derivatives: structure-activity relationships causing parkinsonism-like symptoms.

  1991cites this paper
• MPTP mechanisms of neurotoxicity and their implications for Parkinson's disease.

  1991cites this paper
• Characterization of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) binding sites in C57BL/6 mouse brain: mutual effects of monoamine oxidase inhibitors and sigma ligands on MPTP and sigma binding sites.

  1991cites this paper
• Trapping of reactive intermediates by incorporation of 14C-sodium cyanide during microsomal oxidation.

  1991cites this paper
• Oxidation of toxic and carcinogenic chemicals by human cytochrome P-450 enzymes.

  1991cites this paper
• [Fluorometric determination of monoaminoxidase activity with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine as substrate].

  1991cites this paper
• [Parkinsonism and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (review of the literature)].

  1991cites this paper
• Radioimmunoassay of nicotine-delta 1'(5')-iminium ion, an intermediate formed during the metabolism of nicotine to cotinine.

  1990cites this paper